InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by F2 Vision SCS. Director active across 1 company, notably Cullinan Oncology, Inc.. In total, 3 filings have been logged. Split: 0 buy · 2 sells. Total volume traded: €2.4m. Activity tracked since 12 May 2022. The latest transaction was disclosed on 2 August 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
F2 Vision SCS is a declarant linked to Cullinan Oncology, Inc. It has 4 filings in total, and the sampled recent filings, from 2022-01-13 to 2022-08-04, show sales of EUR 2,419,780 and no purchases.